Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Too many women are dying from cervix cancer: Problems and solutionsGaffney, David K. ; Hashibe, Mia ; Kepka, Deanna ; Maurer, Kathryn A. ; Werner, Theresa L.Gynecologic oncology, 2018-12, Vol.151 (3), p.547-554 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trialMirza, Mansoor Raza, MD ; Åvall Lundqvist, Elisabeth, PhD ; Birrer, Michael J, Prof ; dePont Christensen, Rene, PhD ; Nyvang, Gitte-Bettina, MD ; Malander, Susanne, PhD ; Anttila, Maarit, PhD ; Werner, Theresa L, MD ; Lund, Bente, MD ; Lindahl, Gabriel, MD ; Hietanen, Sakari, PhD ; Peen, Ulla, MD ; Dimoula, Maria, MD ; Roed, Henrik, DMSci ; Ør Knudsen, Anja, MD ; Staff, Synnöve, PhD ; Krog Vistisen, Anders, MD ; Bjørge, Line, Prof ; Mäenpää, Johanna U, ProfThe lancet oncology, 2019-10, Vol.20 (10), p.1409-1419 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapyFrancis, Samual R. ; Ager, Bryan J. ; Do, Olivia A. ; Huang, Yu-Huei Jessica ; Soisson, Andrew P. ; Dodson, Mark K. ; Werner, Theresa L. ; Sause, William T. ; Grant, Jonathan D. ; Gaffney, David K.Gynecologic oncology, 2019-07, Vol.154 (1), p.38-44 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
Combating subclonal evolution of resistant cancer phenotypesBrady, Samuel W ; McQuerry, Jasmine A ; Qiao, Yi ; Piccolo, Stephen R ; Shrestha, Gajendra ; Jenkins, David F ; Layer, Ryan M ; Pedersen, Brent S ; Miller, Ryan H ; Esch, Amanda ; Selitsky, Sara R ; Parker, Joel S ; Anderson, Layla A ; Dalley, Brian K ; Factor, Rachel E ; Reddy, Chakravarthy B ; Boltax, Jonathan P ; Li, Dean Y ; Moos, Philip J ; Gray, Joe W ; Heiser, Laura M ; Buys, Saundra S ; Cohen, Adam L ; Johnson, W Evan ; Quinlan, Aaron R ; Marth, Gabor ; Werner, Theresa L ; Bild, Andrea HNature communications, 2017-11, Vol.8 (1), p.1231-15, Article 1231 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarkerKelley, Kristen C ; Grossman, Kenneth F ; Brittain-Blankenship, Mary ; Thorne, Kelli M ; Akerley, Wallace L ; Terrazas, Moises C ; Kosak, Ken M ; Boucher, Kenneth M ; Buys, Saundra S ; McGregor, Kimberly A ; Werner, Theresa L ; Agarwal, Neeraj ; Weis, John R ; Sharma, Sunil ; Ward, John H ; Kennedy, Thomas P ; Sborov, Douglas W ; Shami, Paul JBMC cancer, 2021-05, Vol.21 (1), p.510-510, Article 510 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Prognostic factors for rural endometrial cancer patients in a population-based cohortBlackburn, Brenna E ; Soisson, Sean ; Rowe, Kerry ; Snyder, John ; Fraser, Alison ; Deshmukh, Vikrant ; Newman, Michael ; Smith, Ken ; Herget, Kimberly ; Kirchhoff, Anne C ; Kepka, Deanna ; Werner, Theresa L ; Gaffney, David ; Mooney, Kathi ; Hashibe, MiaBMC public health, 2019-07, Vol.19 (1), p.921-921, Article 921 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancerLheureux, Stephanie ; Matei, Daniela E ; Konstantinopoulos, Panagiotis A ; Wang, Ben X ; Gadalla, Ramy ; Block, Matthew S ; Jewell, Andrea ; Gaillard, Stephanie L ; McHale, Michael ; McCourt, Carolyn ; Temkin, Sarah ; Girda, Eugenia ; Backes, Floor J ; Werner, Theresa L ; Duska, Linda ; Kehoe, Siobhan ; Colombo, Ilaria ; Wang, Lisa ; Li, Xuan ; Wildman, Rachel ; Soleimani, Shirin ; Lien, Scott ; Wright, John ; Pugh, Trevor ; Ohashi, Pamela S ; Brooks, David G ; Fleming, Gini FJournal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e004233 [Periódico revisado por pares]England: BMJ Publishing Group LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by siteAlbright, Frederick ; Teerlink, Craig ; Werner, Theresa L ; Cannon-Albright, Lisa ABMC cancer, 2012-04, Vol.12 (1), p.138-138, Article 138 [Periódico revisado por pares]England: BioMed CentralTexto completo disponível |
|
9 |
Material Type: Artigo
|
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast CancerDang, Chau ; Ewer, Michael S ; Delaloge, Suzette ; Ferrero, Jean-Marc ; Colomer, Ramon ; de la Cruz-Merino, Luis ; Werner, Theresa L ; Dadswell, Katherine ; Verrill, Mark ; Eiger, Daniel ; Sarkar, Sriparna ; de Haas, Sanne Lysbet ; Restuccia, Eleonora ; Swain, Sandra MCancers, 2022-05, Vol.14 (11), p.2596 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
|
10 |
Material Type: Artigo
|
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypesBrady, Samuel W ; McQuerry, Jasmine A ; Qiao, Yi ; Piccolo, Stephen R ; Shrestha, Gajendra ; Jenkins, David F ; Layer, Ryan M ; Pedersen, Brent S ; Miller, Ryan H ; Esch, Amanda ; Selitsky, Sara R ; Parker, Joel S ; Anderson, Layla A ; Dalley, Brian K ; Factor, Rachel E ; Reddy, Chakravarthy B ; Boltax, Jonathan P ; Li, Dean Y ; Moos, Philip J ; Gray, Joe W ; Heiser, Laura M ; Buys, Saundra S ; Cohen, Adam L ; Johnson, W Evan ; Quinlan, Aaron R ; Marth, Gabor ; Werner, Theresa L ; Bild, Andrea HNature communications, 2018-02, Vol.9 (1), p.572-1, Article 572 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |